Assembly | House | Senate | BLR | Audit
Arkansas State Legislature
91st General Assembly - Regular Session, 2017

You are leaving our site and the Bureau of Legislative Research is not responsible for the content of external websites.

Click "Confirm" to continue to District Finder or click the "Cancel" button to stay on the site.

You are leaving our site and the Bureau of Legislative Research is not responsible for the content of external websites.

Click "Confirm" to continue to Arkansas Code and Constitution of 1874 or click the "Cancel" button to stay on the site.

You are leaving our site and the Bureau of Legislative Research is not responsible for the content of external websites.

Click "Confirm" to continue to State of Arkansas or click the "Cancel" button to stay on the site.

You are leaving our site and the Bureau of Legislative Research is not responsible for the content of external websites.

Click "Confirm" to continue to State Government Directory or click the "Cancel" button to stay on the site.

Senate Vote - Tuesday, March 14, 2017 3:42:44 PM

« Back to HB1592
HB1592 - TO PROVIDE PARITY IN HEALTH BENEFIT PLAN COVERAGE BETWEEN ORALLY ADMINISTERED ANTICANCER MEDICATION AND INTRAVENOUSLY ADMINISTERED ANTICANCER MEDICATION.
Yeas: 32

Nays: 0

Non Voting: 2

Present: 0

Excused: 0